CNBC

Pompe drug shortage leaves patients without critical infusions

Cover art for Pompe drug shortage leaves patients without critical infusions

TL;DR: Sanofi's Pompe disease drug shortage has lasted over three months due to manufacturing issues at its Ireland facility, forcing patients to miss critical infusions and raising concerns about permanent health damage. A three-month supply disruption of Sanofi's Pompe disease treatments has forced patients to cancel infusions, raising fears of irreversible health decline.

Gerry Smith,Brad QuickNov 19, 2026

From · · · 3m

TL;DR: Pompe drug shortage leaves patients without critical infusions

A three-month supply disruption of Sanofi's Pompe disease treatments has forced patients to cancel infusions, raising fears of irreversible health decline.

Sanofi's Pompe disease drug shortage has lasted over three months due to manufacturing issues at its Ireland facility, forcing patients to miss critical infusions and raising concerns about permanent health damage. A three-month supply disruption of Sanofi's Pompe disease treatments has forced patients to cancel infusions, raising fears of irreversible health decline.

  • Sanofi's Pompe drug shortage drags on
  • What Pompe disease does to the body
  • How Sanofi's drugs work
  • Manufacturing problems at Ireland facility

Read the story version — the same reporting as a swipeable deck of 10 cards.

Read the original on CNBC

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on sanofi and related topics.